证券记录 · 已归档季度
RVTY
Revvity, Inc. · Healthcare · Medical - Diagnostics & Research
13被追踪持有人
0Δ持有人
18.11M持有股份
$2.02B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +6.4% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 133 | +9 | 66.02M | $7.35B | +14 | −4 |
| Q1 2026 | 126 | -7 | 72.99M | $6.39B | +4 | −12 |
| Q4 2025 | 133 | 0 | 75.39M | $7.30B | +3 | −2 |
| Q3 2025 | 19 | +1 | 44.69M | $3.92B | +1 | −1 |
| Q2 2025 | 16 | +1 | 42.02M | $4.06B | +3 | −2 |
| Q1 2025 | 12 | -1 | 20.50M | $2.17B | — | −1 |
| Q4 2024 | 13 | 0 | 18.11M | $2.02B | +1 | −1 |
| Q3 2024 | 12 | -1 | 11.86M | $1.51B | +1 | −2 |
| Q2 2024 | 13 | — | 11.86M | $1.24B | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 7.63M | +17.8% | $851.76M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 7.63M | +17.8% | $851.76M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (被动) | 5.17M | — | $576.60M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 2.90M | +1.3% | $322.96M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 2.90M | +1.3% | $322.96M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Norges Bank ✦ (被动) | 1.15M | -4.6% | $127.80M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | PRIMECAP Management ✦ | 951.88K | +2.0% | $106.24M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | Gotham Asset Management ✦ | 163.76K | +37.9% | $18.28M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 57.25K | +41.0% | $6.39M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 38.69K | -41.6% | $4.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Millennium Management ✦ | 34.35K | -74.9% | $3.83M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 8.03K | +27.2% | $896,036 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 8.03K | +27.2% | $896,036 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 8.03K | +27.2% | $896,036 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 6.66K | +13.2% | $742,765 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Wellington Management ✦ | 6.66K | +13.2% | $742,765 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 4.08K | 新增 | $455,480 | 0.0% | New | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 3.56K | +4.6% | $396,885 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Marshall Wace ✦ | 3.56K | +4.6% | $396,885 | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Citadel Advisors | $455,480 | 0.0% |
已清仓
| D. E. Shaw & Co. | $446,870 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 495 持有人, 115.11M 股份, $7.19B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
Aug 14
SC 13G/A — T. Rowe Price Investment Management…
Aug 14
SC 13G/A — PRICE T ROWE ASSOCIATES INC /MD/
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据